Using TCGA publicly available expression profiles of cancer patients, we found that BRCA1 and BRCA2 were widely expressed in multiple tumors compared with normal tissues (Supplementary Figure 3), including breast invasive carcinoma (BRCA), liver hepatocellular carcinoma (LIHC), and rectum adenocarcinoma (READ). This evidence concerns the gene BRCA1 and invasive breast carcinoma.